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Background:  To investigate the safety of performing MRI examinations in patients with implantable cardiac devices
methods:  IRB approved HIPAA compliant study following implementation of a standardized protocol including 42 consecutive patients 
(Mean age 69 years; 61.9% males, 38.2% females) with implantable cardiac devices performing 60 MRI examinations. Patients underwent 
clinical evaluation by a electrophysiologist and device interrogation before and after imaging. Measurement of lead impedances, sensing 
amplitudes and pacing thresholds were recorded for all cases. Pacing mode was changed to asynchronous for pacemaker-dependent 
patients and to “demand” for others. Magnet response and tachyarrhythmia functions were disabled. Paired t-tests were used to compare 
values before and after MRI examination. Significance levels were set at .05 and data was analyzed using SAS statistical package
results:  Of the 42 patients, 25 (59.6%) had a pacemaker (21.4% dependant), and 17 (40.4%) had an implantable defibrillator. No 
episodes of inappropriate inhibition or pacer activation were observed. Four patients (6.67%) engaged in back-up mode. No significant 
differences between baseline and post-scan lead impedances, capture amplitude and capture duration were noted. Diagnostic questions 
were answered in all studies
conclusion:  A standardized protocol to evaluate patients with implantable cardiac devices is a quality initiative that allows safe 
performance of MRI examinations 
Pre and post-procedural device interrogation variable differences
Variable Baseline(Mean, SD)
Post-procedural interrogation
(Mean, SD)
Difference immediately after MRI
(Absolute % Change, SD) P-value
Atrial Lead Impedance, Ω 454.5 +/- 64.70 453.5 +/- 65.10 0.084 +/- 8.637 0.842
Ventricular Lead Impedance, Ω 472.1 +/- 94.18 478.2 +/- 99.29 1.69 +/- 10.86 0.313
Atrial Capt Amp, mV 0.936 +/- 0.534 0.947 +/- 0.550 -0.002 +/- 0.423 0.744
Ventricular Capt Amp, mV 0.962 +/- 0.556 0.966 +/- 0.584 -0.003 +/- 0.379 0.946
Atrial Cap Dur, mSec 0.432 +/- 0.061 0.469 +/- 0.186 -0.016 +/- 0.164 0.251
Ventricular Cap Dur, mSec 0.426 +/- 0.048 0.518 +/- 0.529 -0.076 +/- 0.486 0.227
